Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

/EIN News/ -- MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst & Young LLP (EY US) Entrepreneur Of The Year 2025 Florida Award.

“It’s an honor to be recognized as a trailblazer with this nomination from Ernst & Young,” said Mr. McCallum. “It has been a privilege to work alongside such an incredibly talented group of professionals who have committed themselves to honoring the legacies of donors by bringing transformative, restorative solutions to patients with a range of orthopedic and wound-related conditions. Alongside my colleagues Barry Salzman, Co-President and Chief Operating Officer, and Rey Pascual, Co-President and General Counsel, we are humbled to be considered for this award and look forward to continuing our mission of advancing what we believe to be paradigm shifting solutions to patients in need of tomorrow’s innovations, today.”

An independent panel of judges selected Mr. McCallum among 25 finalists for their entrepreneurial spirit, purpose, growth and lasting impact in building long-term value.

Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries, and making a profound impact on the communities they serve. This award honors business leaders who bootstrapped their businesses from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory; and multigenerational family business leaders who reimagined a legacy business model to strengthen it for the future.

Regional award winners will be announced on June 13 during a special celebration in Orlando and will become lifetime members of an esteemed community of “Entrepreneur Of The Year” alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum^®, one of the nation’s most prestigious gatherings of high-growth, market-leading companies.

About Vivex Biologics, Inc.

Vivex Biologics is a pioneer in advancing allografts that help patients suffering from musculoskeletal injuries, wounds, and burned skin. By leveraging the resources of the nation's oldest civilian tissue bank, Vivex is channeling the body's inherent healing qualities to bring patients optimal care and to provide medical professionals and patients with innovative treatment options for a broad range of indications.

About Entrepreneur Of The Year
Founded in 1986, Entrepreneur Of The Year has celebrated more than 11,000 ambitious visionaries who are leading successful, dynamic businesses in the US, and it has since expanded to nearly 60 countries globally.

The US program consists of 17 regional programs whose panels of independent judges select the regional award winners every June. Those winners compete for national recognition at the Strategic Growth Forum^® in November where National finalists and award winners are announced. The overall National winner represents the US at the EY World Entrepreneur Of The Year™ competition. Visit ey.com/us/eoy.

About EY
EY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets.

Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow.

EY teams work across a full spectrum of services in assurance, consulting, tax, strategy and transactions. Fueled by sector insights, a globally connected, multi-disciplinary network and diverse ecosystem partners, EY teams can provide services in more than 150 countries and territories.

All in to shape the future with confidence.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.

Media Contact
Kathryn Larson, VP of Marketing
klarson@vivex.com